GlassScriptPhysician profile
Sandra A Cole
NPI 1447785944
$11,247.20
in general payments reported to CMS, 2019-2025
14 companies · $5,331 in 2025
The $5,331 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,800 · 2023: $1,854 · 2024: $1,263 · 2025: $5,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,836 · Food and Beverage: $3,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,835.95 |
| Food and Beverage | $3,611.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,436.63 | 2022-2025 | Endurant Iis, Venaseal, Turbohawk |
| Silk Road Medical, INC. | $1,313.49 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $950.95 | 2025 | Smartclaw, General - Vascular Intervention, Eluvia |
| Endologix LLC | $546.45 | 2022-2025 | Endocross Device, Torus Stent Graft System |
| Stryker Corporation | $328.85 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| W. L. Gore & Associates, INC. | $280.49 | 2023-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Propaten Vascular Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Ge Healthcare | $116.25 | 2025 | |
| Lemaitre Vascular, INC. | $84.81 | 2025 | Artegraft Vascular Graft |
| E.R. Squibb & Sons, L.L.C. | $78.48 | 2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $54.78 | 2024-2025 | |
| Penumbra, INC. | $14.75 | 2023 | Penumbra System |
| Cook Medical LLC | $14.28 | 2023 | Cook |
| Biotronik INC. | $14.05 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.